Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma. - Wikidata - awgldk - TriplyDB

Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma.

Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma.

http://www.wikidata.org/entity/Q37449210

about

Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review.The assessment of tumor response by measuring the single largest lesion per organ in metastatic tumors: a pooled analysis of previously reported data.Nucleotide excision repair gene polymorphisms and prognosis of non-small cell lung cancer patients receiving platinum-based chemotherapy: A meta-analysis based on 44 studies.Comparison of RECIST 1.0 and RECIST 1.1 in Patients with Metastatic Cancer: A Pooled Analysis Comparison of the RECIST 1.0 and RECIST 1.1 in Non-Small Cell Lung Cancer Treated with Cytotoxic Chemotherapy.Tumor response assessment by the single-lesion measurement per organ in small cell lung cancer.Comparison of the RECIST 1.0 and RECIST 1.1 in patients treated with targeted agents: a pooled analysis and review.Anti-epidermal growth factor receptor monoclonal antibody-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of PIK3CA mutations in KRAS wild-type patients.Diagnostic and therapeutic imaging for cancer: therapeutic considerations and future directions.XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis.Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?A practical guide to the handling and administration of talimogene laherparepvec in Europe.Unidimensional measurement may be superior to assess primary tumor response after neoadjuvant chemotherapy for nasopharyngeal carcinoma.Relationship between 6- and 9-month progression-free survival and overall survival in patients with metastatic urothelial cancer treated with first-line cisplatin-based chemotherapy.

P2860

Q26749119-09B0FFB3-0C80-4437-94DE-BFAAA6A96BBF Q30882874-FDDE3CA6-5F51-4A83-AB3D-7B1565F5772B Q33733507-F8A13DEF-4494-43D1-8558-CDBA8B08AC38 Q35148109-B3592795-378E-4BEA-A73F-B13AA9E5D3CD Q35739540-92836EFA-7DD8-49CF-B8A2-716514CEB089 Q36897213-41333A5A-F620-4BE6-A572-8350BACB7083 Q37046433-AF18765B-CDED-41D8-8248-C22E3C0D5DB5 Q37636844-D52C64A5-8927-42D6-8CB4-85F2961D48D6 Q37863631-31E147F5-5625-493A-8773-1D2EF671C204 Q38072637-6671F8B0-3A25-4E9F-9894-92565C2460D7 Q38343383-7094AF35-9EAC-480B-9EF9-78F7DDC9AB61 Q40080717-5D906281-B597-450C-93DD-E20913198943 Q41470825-4EB1F121-FAE8-4D57-8447-A0399B59F97D Q45718951-A595976C-1F34-4E50-8423-42A155FC2427

P2860

Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma.

http://www.wikidata.org/entity/Q37449210

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 October 2005

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma.

@en

Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma.

@nl

type

label

Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma.

@en

Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma.

@nl

prefLabel

Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma.

@en

Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma.

@nl

P1433

Q37449210-99605D36-0F8C-433F-816E-2AFC1F71EABD

P1476

Q37449210-BBC49E04-5D75-417C-A5FA-C3EF5C0516EB

P2093

Q37449210-0574B4C3-C5DA-496F-AB13-3BAB357DAEF5

Q37449210-22264168-CF62-4B15-8503-8F85EF681DEF

Q37449210-27295367-3178-4EDC-A90D-B3F055103744

Q37449210-4362869A-545A-4956-BDCE-4A80A0E8FE6D

Q37449210-46E39C90-73BB-48E7-8FD3-562FA34299C0

Q37449210-4DD40F82-8B7E-4433-ACA9-09888B4FA3CF

Q37449210-BB55F4AD-0B2F-40D6-93FB-DAA5B879C951

P2860

Q37449210-1E7F7FE5-24DB-41AE-87D0-628B147FDB38

Q37449210-2F731161-8C46-43C7-90CD-5374633EC93B

Q37449210-56171200-7352-45B1-9677-BECE8EB6EADF

Q37449210-69B59F7D-9EFB-4C15-887A-A9DFDC83E7B7

Q37449210-8F373740-6697-41AD-9E99-D9C1E8576374

Q37449210-B085F1B0-F3BB-4CA4-A093-4AB064CFCF0C

Q37449210-BAD8CFDD-4EAD-44EA-AAF7-4F205C983BA4

P304

Q37449210-AF16E875-9803-4692-A321-51D63E73CFD5

P31

Q37449210-042C709D-1D26-4AF4-AB7E-6098F4106227

P356

Q37449210-76156A55-0D87-41D3-BAD9-828040D06CE4

P433

Q37449210-9C85D847-9740-49BB-835F-AC7BF698D4E9

P478

Q37449210-4DE0FB76-D777-4A04-B18C-8C1A8688A9F3

P577

Q37449210-8AC1A123-90DA-4F4F-A18A-640523CBD8D2

P5875

Q37449210-71A9BAB8-22ED-4793-A9BE-2C949902EA37

P698

Q37449210-DFFBA7AC-AE71-4D64-925B-7C8B573D0BAA

P921

Q37449210-985B17AC-8D25-4C46-8A31-4ABC91011F31

P932

Q37449210-EAA950FC-A788-40D2-A68A-B35F6BC14ECA

P356

CRT.2005.37.5.290

P1433

Cancer Research and Treatment

P1476

Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma.

@en

P2093

Gang-Hong Lee

http://www.w3.org/2001/XMLSchema#string

Hyan-Chul Rhim

http://www.w3.org/2001/XMLSchema#string

In-Soon Kim

http://www.w3.org/2001/XMLSchema#string

Jin-Woo Kim

http://www.w3.org/2001/XMLSchema#string

Jung-Hye Choi

http://www.w3.org/2001/XMLSchema#string

Myung-Ju Ahn

http://www.w3.org/2001/XMLSchema#string

Young-Yeul Lee

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Reporting results of cancer treatment

Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria.

Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer.

Radiological measurement of breast cancer metastases to lung and liver: comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines.

Measuring response in solid tumors: comparison of RECIST and WHO response criteria.

Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response.

P304

290-293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4143/CRT.2005.37.5.290

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40443611

http://www.w3.org/2001/XMLSchema#string

P698

19956529

http://www.w3.org/2001/XMLSchema#string

P921

Alþjóðaheilbrigðismálastofnunin

P932

2785927

http://www.w3.org/2001/XMLSchema#string